Geniko Nosokomeio Peiraia Tzaneio
- Address
- lock Available on a paid plan
Bacterial Infections and Mycoses
The Cardiology Clinic at Geniko Nosokomeio Peiraia Tzaneio is conducting research aimed at improving treatment of severe infections through more precise antibiotic use.
- Use of procalcitonin-guided therapy to tailor antibiotic duration
- Implementation of molecular diagnostics for rapid pathogen identification
- Strategies to reduce exposure to broad‑spectrum antibiotics
These efforts seek to lower resistance risk while maintaining patient safety.
Cardiovascular Diseases
Studies at the site focus on patients with atrial fibrillation to evaluate new anticoagulant options for preventing stroke and systemic embolism.
- Comparison of novel oral anticoagulant asundexian with standard therapy
- Assessment of major bleeding outcomes using international criteria
- Overall benefit‑risk profiling for stroke prevention
The goal is to identify safer and equally effective strategies for individuals at high cardiovascular risk.
Immune System Diseases
The clinic is also exploring treatments for Atopic Dermatitis, testing a biologic agent combined with topical therapy.
- Evaluation of rocatinlimab added to corticosteroids or calcineurin inhibitors
- Measurement of disease severity using validated scores
- Placebo‑controlled assessment of symptom improvement
This research aims to enhance long‑term control of moderate‑to‑severe eczema.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 9 therapeutic areas and 15 of 47 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 44 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +4 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 173 other sites in Greece
Therapeutic Area Benchmark — Greece
Select a therapeutic area to compare against other sites in Greece.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Greece
Market Share
Country: Greece
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Geniko Nosokomeio Peiraia Tzaneio
lock Showing 1 of 22 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Protocol to Evaluate the Efficacy and Safety of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease | Janssen Cilag International | Phase IV | Recruiting | Dec 2025 | — |
IMP list
lock Showing 1 of 47 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Sodium Chloride | 4 | Unknown | 2024-03-25 | 2025-08-29 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.